Editorial Commentary
Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity?
Translational Cancer Research
2025;
14
(11)
:7463-7466
.
(30 November 2025)
Chemotherapy-free combination strategies in recurrent platinum-resistant ovarian cancer: promise, evidence and perspectives
Translational Cancer Research
2025;
14
(11)
:7467-7471
.
(30 November 2025)
Translating NSABP B-51 findings into practice: rethinking regional nodal irradiation in breast cancer
Translational Cancer Research
2025;
14
(11)
:7472-7477
.
(30 November 2025)
Racial disparities in ovarian cancer survival transcend the somatic mutational landscape
Translational Cancer Research
2025;
14
(11)
:7478-7479
.
(30 November 2025)
Original Article
Sorting nexin 9 expression and prognostic implications in lung adenocarcinoma: integrative bioinformatic and in vitro validation
Translational Cancer Research
2025;
14
(11)
:7480-7493
.
(30 November 2025)
Machine learning prediction of overall survival in patients with primary gastrointestinal melanoma
Translational Cancer Research
2025;
14
(11)
:7494-7506
.
(30 November 2025)
LINC02081 as an oncogene promotes cell proliferation and G2/M cycle through p53 signaling pathway in lung adenocarcinoma
Translational Cancer Research
2025;
14
(11)
:7507-7520
.
(30 November 2025)
A novel pyridazinone and thiophene compound IMB5043 activated apoptosis and autophagy in cisplatin-resistant non-small cell lung cancer cells
Translational Cancer Research
2025;
14
(11)
:7521-7535
.
(30 November 2025)
Ubiquitin-conjugating enzyme E2S serves as a prognostic marker for skin cutaneous melanoma
Translational Cancer Research
2025;
14
(11)
:7536-7549
.
(30 November 2025)
Clinical characteristics and prognosis of elderly patients with gastric gastrointestinal stromal tumors: a population-based study
Translational Cancer Research
2025;
14
(11)
:7550-7562
.
(30 November 2025)
Thermal ablation versus surgical resection for colorectal liver metastases: a Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-assessed systematic review, survival meta-analysis, and meta-regression
Translational Cancer Research
2025;
14
(11)
:7563-7579
.
(30 November 2025)
PM2.5 promotes non-small cell lung cancer tumorigenesis by miR-21-5p targeting PDE4DIP accumulated
Translational Cancer Research
2025;
14
(11)
:7580-7597
.
(30 November 2025)
ZBTB7B modulates the androgen receptor as an upstream regulator via colocalization and direct binding in LNCaP prostate cancer cells
Translational Cancer Research
2025;
14
(11)
:7598-7610
.
(30 November 2025)
Prognostic characteristics and recurrence patterns of grade 1 endometrial carcinoma: a large retrospective analysis of a tertiary center
Translational Cancer Research
2025;
14
(11)
:7611-7620
.
(30 November 2025)
Neutrophil depletion dampens inflammation and enhances CD8+ T cell effect on tumor control but undermines anti-PD-1 therapy
Translational Cancer Research
2025;
14
(11)
:7621-7640
.
(30 November 2025)
Curcumin induces ferroptosis in hepatocellular carcinoma by regulating PERK/Nrf2/HO-1 signaling pathway
Translational Cancer Research
2025;
14
(11)
:7641-7653
.
(30 November 2025)
Clinical characteristics and long-term prognosis of primary mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma in the small intestine
Translational Cancer Research
2025;
14
(11)
:7654-7668
.
(30 November 2025)
Genetic insights into colorectal cancer pathogenesis: a multi-omics and immunity perspective
Translational Cancer Research
2025;
14
(11)
:7669-7685
.
(30 November 2025)
Development and validation of a pathomics model to predict SOX11 expression and prognosis in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(11)
:7686-7699
.
(30 November 2025)
Causal relationship between hypertension and cancer: a two‐sample bidirectional Mendelian randomization study
Translational Cancer Research
2025;
14
(11)
:7700-7711
.
(30 November 2025)
Risk factors for refractory malignant pleural effusion and the impact on prognosis in non-small cell lung cancer patients with advanced EGFR mutations: a retrospective cohort study using propensity score matching
Translational Cancer Research
2025;
14
(11)
:7712-7724
.
(30 November 2025)
A new combined prognostic model involving SLC44A4 improves the predictive ability for colorectal cancer patients
Translational Cancer Research
2025;
14
(11)
:7725-7740
.
(30 November 2025)
Impact of single-site distant metastases on prognosis in advanced ovarian cancer: a Surveillance, Epidemiology, and End Results population-based study
Translational Cancer Research
2025;
14
(11)
:7741-7757
.
(30 November 2025)
Identification and prognostic assessment of clonal and functional heterogeneity in head and neck squamous cell carcinoma
Translational Cancer Research
2025;
14
(11)
:7758-7772
.
(30 November 2025)
Clinicopathological characteristics and long-term prognosis of duodenal signet ring cell carcinoma: a SEER-based analysis
Translational Cancer Research
2025;
14
(11)
:7773-7789
.
(30 November 2025)
Dietary restriction-responsive genes define prognostic subtypes and predict metastasis in colorectal cancer
Translational Cancer Research
2025;
14
(11)
:7790-7809
.
(30 November 2025)
ING5-mediated regulation of lung cancer progression via the OIP5-AS1/miR-381-3p/SEC24A axis
Translational Cancer Research
2025;
14
(11)
:7810-7823
.
(30 November 2025)
Bioinformatics-based multi-omics and machine learning analysis identifies stemness-associated molecular subtypes and a prognostic index in breast cancer
Translational Cancer Research
2025;
14
(11)
:7824-7846
.
(30 November 2025)
MCRS1 is associated with immunosuppressive microenvironments in pan-cancer and promotes hepatocellular carcinoma malignant phenotypes
Translational Cancer Research
2025;
14
(11)
:7847-7869
.
(30 November 2025)
Expression and role of PD-L1 and SOX10 in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(11)
:7870-7880
.
(30 November 2025)
Developing of potential mRNA vaccines based on tumor antigens and immune subtypes of esophageal cancer
Translational Cancer Research
2025;
14
(11)
:7881-7902
.
(30 November 2025)
The influence of tumor location on the onset of endocrine deficits in pediatric brain tumor survivors
Translational Cancer Research
2025;
14
(11)
:7903-7911
.
(30 November 2025)
Prediction of postoperative survival in patients with head and neck acinic cell carcinoma: a population-based study
Translational Cancer Research
2025;
14
(11)
:7912-7925
.
(30 November 2025)
Evaluation of nomogram prediction model for postoperative deep vein thrombosis in patients with non-small cell lung cancer
Translational Cancer Research
2025;
14
(11)
:7926-7937
.
(30 November 2025)
NFATc1 activates the Ras/Raf/p38 MAPK pathway to promote the progression of lung adenocarcinoma
Translational Cancer Research
2025;
14
(11)
:7938-7953
.
(30 November 2025)
Association between cholecystectomy and colorectal cancer: results from the National Health and Nutrition Examination Survey (NHANES) 2017–2023 and Mendelian randomization analyses
Translational Cancer Research
2025;
14
(11)
:7954-7966
.
(30 November 2025)
Development and validation of a delta ultrasomics model for predicting treatment response to neoadjuvant chemotherapy in breast cancer
Translational Cancer Research
2025;
14
(11)
:7967-7979
.
(30 November 2025)
Significance of the association between hypoxia and pyroptosis-related genes in the prognostic prediction of glioblastoma: insights from model construction and validation
Translational Cancer Research
2025;
14
(11)
:7980-7994
.
(30 November 2025)
Identification of the key gene for hepatocellular carcinoma based on bioinformatics and machine learning and experimental verification
Translational Cancer Research
2025;
14
(11)
:7995-8011
.
(30 November 2025)
SAMD4B: a novel prognostic biomarker of endometrial carcinoma
Translational Cancer Research
2025;
14
(11)
:8012-8021
.
(30 November 2025)
Circulating tumor cells as a recurrence risk marker in glioma: a retrospective study
Translational Cancer Research
2025;
14
(11)
:8022-8031
.
(30 November 2025)
Fatty acid metabolism-related signature suggests an oncogenic role of FASN in cervical cancer
Translational Cancer Research
2025;
14
(11)
:8032-8054
.
(30 November 2025)
Application value of a prognostic risk model based on lactate-related genes in non-small cell lung cancer
Translational Cancer Research
2025;
14
(11)
:8055-8069
.
(30 November 2025)
Uridine-cytidine kinase 2 as a novel potential prognostic and therapeutic biomarker in gastric cancer
Translational Cancer Research
2025;
14
(11)
:8070-8085
.
(30 November 2025)
Engineered macrophages accumulate in solid tumors and locally deliver immune-activating proteins to inhibit tumor progression
Translational Cancer Research
2025;
14
(11)
:8086-8104
.
(30 November 2025)
Association of the aggregate index of systemic inflammation in cancer survivors with all-cause, cardiovascular, and cancer- related mortality
Translational Cancer Research
2025;
14
(11)
:8105-8118
.
(30 November 2025)
Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China
Translational Cancer Research
2025;
14
(11)
:8119-8131
.
(30 November 2025)
Prognostic potential of N6-methyladenosine methylation-associated genes in lung adenocarcinoma
Translational Cancer Research
2025;
14
(11)
:8132-8141
.
(30 November 2025)
Review Article
Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events—a narrative review
Translational Cancer Research
2025;
14
(11)
:8142-8153
.
(30 November 2025)
On the translational potential of atlases in precision oncology
Translational Cancer Research
2025;
14
(11)
:8154-8165
.
(30 November 2025)
A narrative review of segmentectomy versus lobectomy in elderly patients with early-stage NSCLC: challenging the longstanding standard
Translational Cancer Research
2025;
14
(11)
:8166-8175
.
(30 November 2025)
Advancing circular economy practices in radiography: a narrative review of sustainable medical imaging
Translational Cancer Research
2025;
14
(11)
:8176-8200
.
(30 November 2025)
Case Report
Long-term survival in a patient with leptomeningeal metastases from non-small cell lung cancer treated with stereotactic radiotherapy (SRT), programmed cell death protein 1 (PD-1) inhibitor, and granulocyte-macrophage colony-stimulating factor (GM-CSF): a case report
Translational Cancer Research
2025;
14
(11)
:8201-8209
.
(30 November 2025)
Clinical case report on the efficacy and safety of savolitinib in elderly patients with non-small cell lung cancer harboring METex14 skipping mutations
Translational Cancer Research
2025;
14
(11)
:8210-8217
.
(30 November 2025)
